DCI

DonaldsonB

NYSE / Capital Goods

Quote time unavailable

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

20%

Probability

Target price

$105.00

Analysis reference price unavailable

Analysis 2026-09-16 · RankAlpha Sentiment Codex

Most likely

Base case

55%

Probability

Target price

$89.00

Analysis reference price unavailable

Analysis 2026-09-16 · RankAlpha Sentiment Codex

B-

Bear case

25%

Probability

Target price

$72.00

Analysis reference price unavailable

Analysis 2026-09-16 · RankAlpha Sentiment Codex

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2026-09-16

AI commentary

News tone remains constructive following record fiscal-year results and FY2027 guidance, but financing costs, acquisition dilution and execution issues temper the interpretation. The $87.06 anchor is below the roughly $91 transaction prices disclosed in late-August and early-September Form 4 filings, suggesting some post-print enthusiasm has faded. Formal post-earnings analyst revisions, options data, employee data and sufficient social coverage are unavailable; missing revision evidence is not treated as positive.

RankAlpha Sentiment Codex - 2026-09-16

Open full AI memo

Evidence flagged

peer set is too generic or lacks enough direct operating comparators

Impact

tentative

Confidence

AI events

2026-08-26eventFY2026 records establish the FY2027 benchmarkMedium impact

Donaldson reported fourth-quarter sales of $1.0588 billion and adjusted EPS of $1.15, then guided to FY2027 sales growth of 5.5%-9.5% and adjusted EPS of $4.22-$4.38. The results release was furnished with the August 26 Form 8-K. [#IR-2026-08-26] [#SEC-8K-2026-08-26]

2027-01-31catalystFirst-half execution and Facet dilution testMedium impact

Operational inefficiencies from production transfers and aerospace supply constraints may persist through the first half of FY2027, while Facet-related amortization and financing costs are expected to dilute FY2027 EPS by about $0.12. Evidence of recovery by the fiscal second-quarter checkpoint would reduce execution risk. [#IR-2026-08-26]

2027-07-31catalystDelivery of segment growth and margin guidanceHigh impact

Management's FY2027 plan calls for mid-teens Industrial Solutions growth, 7%-11% Life Sciences growth, 2%-6% Mobile Solutions growth, and a 16.6%-17.2% operating margin. Sustained aftermarket demand, China momentum and power-generation backlog conversion could support another record year, but the outcome remains execution-dependent. [#IR-2026-08-26]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-09-16 • Updated nightlySource: Internal modelMethodology